Pharmaceutical MedTech Analysis l Report Store l Pharma Intelligence

The Global Molecular Diagnostics Market

The molecular diagnostic products market is the highest growth segment of the global in vitro diagnostics (IVDs) market valued at an estimated $5.3 billion in 2014 and projected to grow at a compound annual growth rate of 6.6% to $7.3 billion by the year 2019.

September 22, 2016

Find out more

U.S. Markets for Stroke Management

$4,750.00

The United States (U.S.) market for stroke management products, which encompasses diagnostic and therapeutic systems, is a market composed of old and new technologies that are often used together in order to prevent and treat stroke. Improvements in stroke diagnostic systems will facilitate the delivery of timely stroke therapies within the optimum treatment window for patients suffering from stroke.

September 22, 2016

Find out more

U.S. Markets for Advanced Wound Care Products

$4,750.00

U.S. Markets for Advanced Wound Care Products

September 22, 2016

Find out more

U.S. Markets for Drug and Fluid Delivery Devices

$5,250.00

Pharmacotherapy represents the first-line treatment in the management of most chronic and transient medical conditions warranting therapeutic intervention in the U.S.

December 1, 2015

Find out more

Global Spinal Implants Market

$5,250.00

Spine disorders are a leading driver of healthcare costs worldwide, and range in severity from mild pain and loss of feeling to extreme pain and paralysis. These disorders are primarily caused by degenerative conditions in the spine, deformity, tumors and trauma.

December 1, 2015

Find out more

Global Radiation Therapy Systems Market, March 2016

$3,750.00

This report covers the large, highly competitive, technology driven Global Market for Radiation Therapy Systems—valued at nearly $4.3 billion in 2015.

March 1, 2016

Find out more

Asia-Pacific Disease Incidence and Prevalence

$5,250.00

The Asia-Pacific (APAC) region is a part of the world which includes several developing and developed countries. Countries covered in this report include Australia, China, India, Japan, Malaysia, South Korea, Thailand, and Vietnam.

January 1, 2016

Find out more

U.S. Markets for Interventional Cardiology Products, April 2016

$4,750.00

In the United States (U.S.), approximately 85.6 million adults have at least one type of cardiovascular disease (CVD), a broad group of disorders that affect the heart and circulatory system. Cardiovascular disease in all its forms accounts for more deaths than any other major cause in the U.S.

April 1, 2016

Find out more

International Markets for Vascular Access Site Closure Devices

$4,750.00

Cardiovascular diseases (CVDs) are the leading causes of death throughout the world. Based on Datamonitor Healthcare estimates, approximately 500 million CVD-related cases occurred in the United States (U.S.), China, Japan, and the five major countries of Europe (France, Germany, Italy, Spain, and the United Kingdom [U.K.]).

June 30, 2016

Find out more

U.S. Markets for Pharmacologic and Device-Based Approaches to Pain Management

$4,750.00

More than 40% of people in the U.S. say they have experienced recent pain, with 8% suffering from chronic pain. Direct healthcare costs associated with the treatment of pain total nearly $300 billion annually.

April 4, 2016

Find out more

Global Neurostimulation Devices Market, June 2016

$4,750.00

The large and burgeoning global market for implantable neurostimulation devices is approaching nearly $4 billion worldwide. Despite lingering economic uncertainty and financial constraints that have affected many other medical device markets, this market is undergoing significant technological advancement due to heavy R&D and investment efforts by dozens of innovative startups and leading medical device companies.

June 1, 2016

Find out more

U.S. Markets for Respiratory Care Products, June 2016

$4,750.00

The annual U.S. economic burden of respiratory disease is more than $106 billion. Appropriate therapy can reduce direct healthcare costs as well as indirect costs such as lost worker productivity. The combined U.S. market for respiratory products totalled more than $4.4 billion in 2015.

June 20, 2016

Find out more

Brexit and the life sciences: What lies ahead?

$700.00

The UK’s surprise decision to leave the EU has caused a great deal of uncertainty about the country’s future, not least among those working in the UK biopharmaceutical and broader life sciences industry.

August 23, 2016

Find out more

MedTech analysis

The Global Molecular Diagnostics Market

U.S. Markets for Stroke Management

U.S. Markets for Advanced Wound Care Products

U.S. Markets for Drug and Fluid Delivery Devices

Global Spinal Implants Market

Global Radiation Therapy Systems Market, March 2016

Asia-Pacific Disease Incidence and Prevalence

U.S. Markets for Interventional Cardiology Products, April 2016

International Markets for Vascular Access Site Closure Devices

U.S. Markets for Pharmacologic and Device-Based Approaches to Pain Management

Global Neurostimulation Devices Market, June 2016

U.S. Markets for Respiratory Care Products, June 2016

Brexit and the life sciences: What lies ahead?